Explore Starodub latest updates

Medical device market access in the EU: national obligations beyond EUDAMED

Regulatory support for ATMP & Biologics developers

Looking for regulatory expertise to move your (Bio)Pharmaceutical project forward?

28 May is almost here — is your organization EUDAMED‑ready?

Key revisions of Policy Document for Parallel Import of Medicines

Before strategy is written, it is already made

EMA Centralised Procedure – Analysis of Marketing Authorisation Applications

Respiratory Syncytial Virus (RSV) and its growing public health impact.

EMA strengthens PRIME: New tools to accelerate breakthrough medicines in Europe

EMA Updates Guideline on Chemistry of Active Substances

Starodub participation in the 21st BIO KOREA International Convention

CMDh updates Q&A on Generic Drug Submissions – What you need to know?

Dutch Biotech Mission to BIO KOREA 2026

New QP service

How do you achieve good clinical practice under the EU Medical Device Regulation 2017/745?

Why benefit–risk and reimbursement assessments can differ

CE marking for Start-ups and small manufacturers

A First Look at the Future of CMC Documentation in ICH M4Q(R2)

Iryna Berchak
Senior RA Consultant
Iryna Berchak

Let's Connect

Talk to an expert